4.7 Review

What is synergy? The Saariselka agreement revisited

期刊

FRONTIERS IN PHARMACOLOGY
卷 6, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2015.00181

关键词

definition of synergy; drug combinations; Bliss and Loewe models; interaction barometer; consensus agreement

资金

  1. Academy of Finland [272437, 269862, 279163, 292611, 277293]
  2. Cancer Society of Finland
  3. Cancer Foundation Finland sr [140087] Funding Source: researchfish
  4. Academy of Finland (AKA) [277293, 272437, 277293, 279163, 292611, 279163, 292611] Funding Source: Academy of Finland (AKA)

向作者/读者索取更多资源

Many biological or chemical agents when combined interact with each other and produce a synergistic response that cannot be predicted based on the single agent responses alone. However, depending on the postulated null hypothesis of non-interaction, one may end up in different interpretations of synergy. Two popular reference models for null hypothesis include the Bliss independence model and the Loewe additivity model, each of which is formulated from different perspectives. During the last century, there has been an intensive debate on the suitability of these synergy models, both of which are theoretically justified and also in practice supported by different schools of scientists. More than 20 years ago, there was a community effort to make a consensus on the terminology one should use when claiming synergy. The agreement was formulated at a conference held in Saariselka, Finland in 1992, stating that one should use the terms Bliss synergy or Loewe synergy to avoid ambiguity in the underlying models. We review the theoretical relationships between these models and argue that one should combine the advantages of both models to provide a more consistent definition of synergy and antagonism.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据